TRIO-TECH INTERNATIONAL — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that TRIO-TECH INTERNATIONAL filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Jun 30, 2021 | $32.46M | Oct 1, 2021 |
| FY2021 | Jun 30, 2020 | $34.47M | Oct 1, 2021 |
| FY2020 | Jun 30, 2019 | $39.20M | Sep 23, 2020 |
| FY2019 | Jun 30, 2018 | $42.36M | Sep 23, 2019 |
| FY2018 | Jun 30, 2017 | $38.54M | Sep 25, 2018 |
| FY2013 | Jun 30, 2013 | $32.16M | Sep 27, 2013 |
| FY2013 | Jun 30, 2012 | $34.21M | Sep 27, 2013 |
| FY2012 | Jun 30, 2011 | $35.5K | Oct 9, 2012 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Jun 30, 2017 | $38.54M | Sep 20, 2017 |
| FY2017 | Jun 30, 2016 | $34.45M | Sep 20, 2017 |
| FY2016 | Jun 30, 2015 | $33.93M | Sep 28, 2016 |
| FY2015 | Jun 30, 2014 | $36.26M | Sep 28, 2015 |
| FY2014 | Jun 30, 2013 | $31.77M | Oct 9, 2014 |
| FY2013 | Jun 30, 2012 | $31.10M | Sep 27, 2013 |
| FY2012 | Jun 30, 2011 | $35.54M | Oct 9, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $9.14M | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | $10.76M | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | $11.71M | Sep 23, 2024 |
| FY2023 | Jun 30, 2022 | $11.73M | Sep 27, 2023 |
| FY2022 | Jun 30, 2021 | $7.67M | Sep 23, 2022 |
| FY2021 | Jun 30, 2020 | $7.27M | Oct 1, 2021 |
| FY2020 | Jun 30, 2019 | $9.00M | Sep 23, 2020 |
| FY2019 | Jun 30, 2018 | $10.64M | Sep 23, 2019 |
| FY2018 | Jun 30, 2017 | $9.46M | Sep 25, 2018 |
| FY2017 | Jun 30, 2016 | $8.77M | Sep 20, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($41.0K) | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | $1.05M | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | $1.54M | Sep 23, 2024 |
| FY2023 | Jun 30, 2022 | $2.40M | Sep 27, 2023 |
| FY2022 | Jun 30, 2021 | ($591.0K) | Sep 23, 2022 |
| FY2021 | Jun 30, 2020 | $878.0K | Oct 1, 2021 |
| FY2020 | Jun 30, 2019 | $1.55M | Sep 23, 2020 |
| FY2019 | Jun 30, 2018 | $1.18M | Sep 23, 2019 |
| FY2018 | Jun 30, 2017 | $1.32M | Sep 25, 2018 |
| FY2017 | Jun 30, 2016 | $779.0K | Sep 20, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $254.0K | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | $1.09M | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | $2.23M | Sep 23, 2024 |
| FY2023 | Jun 30, 2022 | $2.35M | Sep 27, 2023 |
| FY2022 | Jun 30, 2021 | ($61.0K) | Sep 23, 2022 |
| FY2021 | Jun 30, 2020 | $879.0K | Oct 1, 2021 |
| FY2020 | Jun 30, 2019 | $1.55M | Sep 23, 2020 |
| FY2019 | Jun 30, 2018 | $1.20M | Sep 23, 2019 |
| FY2018 | Jun 30, 2017 | $1.33M | Sep 25, 2018 |
| FY2017 | Jun 30, 2016 | $788.0K | Sep 20, 2017 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $384.0K | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | $392.0K | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | $397.0K | Sep 23, 2024 |
| FY2023 | Jun 30, 2022 | $375.0K | Sep 27, 2023 |
| FY2022 | Jun 30, 2021 | $357.0K | Sep 23, 2022 |
| FY2021 | Jun 30, 2020 | $355.0K | Oct 1, 2021 |
| FY2020 | Jun 30, 2019 | $345.0K | Sep 23, 2020 |
| FY2019 | Jun 30, 2018 | $451.0K | Sep 23, 2019 |
| FY2018 | Jun 30, 2017 | $208.0K | Sep 25, 2018 |
| FY2017 | Jun 30, 2016 | $200.0K | Sep 20, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $371.0K | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | $2.72M | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | $8.11M | Sep 23, 2024 |
| FY2023 | Jun 30, 2022 | $2.12M | Sep 27, 2023 |
| FY2022 | Jun 30, 2021 | $1.64M | Sep 23, 2022 |
| FY2021 | Jun 30, 2020 | $3.01M | Oct 1, 2021 |
| FY2020 | Jun 30, 2019 | $4.45M | Sep 23, 2020 |
| FY2019 | Jun 30, 2018 | $4.40M | Sep 23, 2019 |
| FY2018 | Jun 30, 2017 | $3.95M | Sep 25, 2018 |
| FY2017 | Jun 30, 2016 | $1.01M | Sep 20, 2017 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $967.0K | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | $542.0K | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | $4.50M | Sep 23, 2024 |
| FY2023 | Jun 30, 2022 | $1.47M | Sep 27, 2023 |
| FY2022 | Jun 30, 2021 | $1.11M | Sep 23, 2022 |
| FY2021 | Jun 30, 2020 | $1.02M | Oct 1, 2021 |
| FY2020 | Jun 30, 2019 | $2.84M | Sep 23, 2020 |
| FY2019 | Jun 30, 2018 | $2.31M | Sep 23, 2019 |
| FY2018 | Jun 30, 2017 | $2.29M | Sep 25, 2018 |
| FY2017 | Jun 30, 2016 | $1.66M | Sep 20, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $41.07M | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | $42.54M | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | $42.19M | Sep 23, 2024 |
| FY2023 | Jun 30, 2022 | $43.42M | Sep 27, 2023 |
| FY2022 | Jun 30, 2021 | $38.31M | Sep 23, 2022 |
| FY2021 | Jun 30, 2020 | $35.66M | Oct 1, 2021 |
| FY2020 | Jun 30, 2019 | $36.53M | Sep 23, 2020 |
| FY2019 | Jun 30, 2018 | $36.47M | Sep 23, 2019 |
| FY2018 | Jun 30, 2017 | $33.50M | Sep 25, 2018 |
| FY2017 | Jun 30, 2016 | $32.22M | Sep 20, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $7.08M | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | $10.96M | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | $12.62M | Sep 23, 2024 |
| FY2023 | Jun 30, 2022 | $15.42M | Sep 27, 2023 |
| FY2022 | Jun 30, 2021 | $12.25M | Sep 23, 2022 |
| FY2021 | Jun 30, 2020 | $10.51M | Oct 1, 2021 |
| FY2020 | Jun 30, 2019 | $11.67M | Sep 23, 2020 |
| FY2019 | Jun 30, 2018 | $12.97M | Sep 23, 2019 |
| FY2018 | Jun 30, 2017 | $11.97M | Sep 25, 2018 |
| FY2017 | Jun 30, 2016 | $11.35M | Sep 20, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $34.03M | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | $31.33M | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | $29.41M | Sep 23, 2024 |
| FY2023 | Jun 30, 2022 | $27.87M | Sep 27, 2023 |
| FY2022 | Jun 30, 2021 | $25.63M | Sep 23, 2022 |
| FY2021 | Jun 30, 2020 | $25.15M | Oct 1, 2021 |
| FY2021 | Jun 30, 2019 | $24.86M | Oct 1, 2021 |
| FY2020 | Jun 30, 2018 | $23.50M | Sep 23, 2020 |
| FY2019 | Jun 30, 2017 | $21.53M | Sep 23, 2019 |
| FY2018 | Jun 30, 2016 | $20.87M | Sep 25, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $12.04M | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | $11.81M | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | $10.76M | Sep 23, 2024 |
| FY2023 | Jun 30, 2022 | $9.22M | Sep 27, 2023 |
| FY2022 | Jun 30, 2021 | $6.82M | Sep 23, 2022 |
| FY2021 | Jun 30, 2020 | $7.42M | Oct 1, 2021 |
| FY2020 | Jun 30, 2019 | $7.07M | Sep 23, 2020 |
| FY2019 | Jun 30, 2018 | $5.53M | Sep 23, 2019 |
| FY2018 | Jun 30, 2017 | $4.34M | Sep 25, 2018 |
| FY2017 | Jun 30, 2016 | $3.03M | Sep 20, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $10.89M | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | $10.04M | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | $7.58M | Sep 23, 2024 |
| FY2023 | Jun 30, 2022 | $7.70M | Sep 27, 2023 |
| FY2022 | Jun 30, 2021 | $5.84M | Sep 23, 2022 |
| FY2018 | Jun 30, 2018 | $6.54M | Sep 25, 2018 |
| FY2018 | Jun 30, 2017 | $4.77M | Sep 25, 2018 |
| FY2018 | Jun 30, 2016 | $3.81M | Sep 25, 2018 |
| FY2017 | Jun 30, 2015 | $3.71M | Sep 20, 2017 |
| FY2016 | Jun 30, 2014 | $2.94M | Sep 28, 2016 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $684.0K | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | $874.0K | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | $1.35M | Sep 23, 2024 |
| FY2023 | Jun 30, 2022 | $1.74M | Sep 27, 2023 |
| FY2022 | Jun 30, 2021 | $2.06M | Sep 23, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Sep 23, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Sep 27, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Sep 23, 2022 |
| FY2021 | Jun 30, 2020 | 0 | Oct 1, 2021 |
| FY2020 | Jun 30, 2019 | 0 | Sep 23, 2020 |
| FY2019 | Jun 30, 2018 | 0 | Sep 23, 2019 |
| FY2018 | Jun 30, 2017 | 0 | Sep 25, 2018 |
| FY2017 | Jun 30, 2016 | 0 | Sep 20, 2017 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Sep 23, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Sep 27, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Sep 23, 2022 |
| FY2021 | Jun 30, 2020 | 0 | Oct 1, 2021 |
| FY2020 | Jun 30, 2019 | 0 | Sep 23, 2020 |
| FY2019 | Jun 30, 2018 | 0 | Sep 23, 2019 |
| FY2018 | Jun 30, 2017 | 0 | Sep 25, 2018 |
| FY2017 | Jun 30, 2016 | 0 | Sep 20, 2017 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 4.31M | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | 4.25M | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | 4.10M | Sep 23, 2024 |
| FY2023 | Jun 30, 2022 | 4.07M | Sep 27, 2023 |
| FY2022 | Jun 30, 2021 | 3.91M | Sep 23, 2022 |
| FY2021 | Jun 30, 2020 | 3.67M | Oct 1, 2021 |
| FY2020 | Jun 30, 2019 | 3.67M | Sep 23, 2020 |
| FY2019 | Jun 30, 2018 | 3.55M | Sep 23, 2019 |
| FY2018 | Jun 30, 2017 | 3.52M | Sep 25, 2018 |
| FY2017 | Jun 30, 2016 | 3.51M | Sep 20, 2017 |